| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Troy A. Ignelzi | Chief Financial Officer | $18,263,346 | 22 Aug 2023 | ||
| Charmaine Lykins | Chief Commercial Officer | $6,922,500 | 29 Nov 2021 | ||
| Heather Preston | Director | $2,861,556 | 24 Jun 2021 | ||
| Jeffrey M. Jonas | Director | $0 | 15 Mar 2024 | ||
| Laurie J. Olson | Director | $0 | 18 Mar 2024 | ||
| William P. Kane Jr. | Chief Commercial Officer | $0 | 18 Mar 2024 | ||
| Andrew Craig Miller | President of R&D | $0 | 18 Mar 2024 | ||
| James Healy | Director | $0 | 18 Mar 2024 | ||
| Atul Pande | Director | $0 | 18 Mar 2024 | ||
| William Meury | President and CEO, Director | $0 | 18 Mar 2024 | ||
| Christopher J. Coughlin | Director | $0 | 18 Mar 2024 | ||
| Stephen K. Brannan | Chief Medical Officer | $0 | 18 Mar 2024 | ||
| David E. Wheadon | Director | $0 | 18 Mar 2024 | ||
| Jason Parker Brown | Chief Financial Officer | $0 | 18 Mar 2024 | ||
| Steven M. Paul | Director | $0 | 18 Mar 2024 | ||
| Denice Torres | Director | $0 | 18 Mar 2024 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||